Cart
sales@molnova.com
TAK1-IN-3
CAS No. 494772-87-1
TAK1-IN-3( —— )
Catalog No. M35215 CAS No. 494772-87-1
TAK1-IN-3 is a novel ATP-competitive TAK1 inhibitor for the study of cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 70 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTAK1-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionTAK1-IN-3 is a novel ATP-competitive TAK1 inhibitor for the study of cancer.
-
DescriptionTAK1-IN-3 is a potent ATP-competitive TAK1 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
RecptorMAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number494772-87-1
-
Formula Weight317.41
-
Molecular FormulaC16H19N3O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (315.05 mM; Ultrasonic )
-
SMILESO=C(N)C=1SC(=CC1N)C=2C=CC(=CC2)CN3CCOCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
VX-745
A potent and selective p38α kinase inhibitor with IC50 of 9 nM; shows 20-fold selectivity for p38α over p38β (Ki=220 nM) and no significant inhibition for MAP kinases (with the exception of MKK6).
-
UR13870
UR-13870 (Org 48762-0) is an orally active and selective inhibitor of p38 mitogen-activated protein kinase (MAPK), which prevents bone damage in collagen-induced arthritis in mice.
-
PF-03715455
PF-03715455 is a highly potent and selective inhibitor for p38α MAPK with IC50 of 1.6 nM.
